I have one last question for you, Mr. Doyle.
On December 10, Enercan participated in a conference call with European officials. It was disclosed at this time that Europe could supply only between 10% and 15% of the isotopes needed, although this represented 50% of MDS's market share. This 10% to 15% corresponds to all of Canada's requirements. The official in charge of the reactor in Belgium clearly said that he can meet all of Canada's needs—not the needs of MDS, but Canada's needs. Yet, it was reported that they could supply only between 10% and 15% of the isotopes required.
Are you aware that this figure represents all of Canada's needs?